Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
Chengdu Chipscreen NewWay Biosciences Co Ltd NewWay announced that on January the dosing of the first patient for a phase I clinical trial of a PDCD bispecific antibody bsAb NWY at Sun YatSen University Cancer Center in China
Boan Biotech recently announced that subject enrollment for the international multicenter comparative clinical study of the companys Denosumab Injections has been completed This study is being conducted simultaneously in Europe
ClinChoice a leading global Contract Research Organization today announced expanding its global footprint with the acquisition of CSI Medical Research CSI is a regional clinical CRO with professional staff and partners
BioPath Holdings Inc a biotechnology company leveraging its proprietary DNAbilize antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid cancer drugs
Menarini Silicon Biosystems a pioneer of liquid biopsy technology announced today the publication in the Journal of Clinical Chemistry of the final results of the multicenter DETECT III clinical trial
Faron Pharmaceuticals Ltd a clinicalstage biopharmaceutical company pursuing a CLEVER approach to reprogramming myeloid cells to activate antitumor immunity in hematological
GC Cell a fully integrated cell therapy pioneer is proud to announce the approval from both the Australian Human Research Ethics Committee and the Korean Ministry of Food and Drug Safety
WuXi AppTec a global company that provides a broad portfolio of RD and manufacturing services that enable companies in the pharmaceutical biotech and medical device industries to advance discoveries and deliver groundbreaking
Independent biopharmaceutical company Specialised Therapeutics Asia Pte Ltd ST has added three new endocrinology therapies to its specialist portfolio following an exclusive distribution agreement
Kexing Biopharm signed an international commercialization cooperation agreement on Eribulin Mesylate Injection securing exclusive commercialization licensing
